drugset / Trial / NCT07025551
A Clinical Study of MK-8527 in Participants With Mild and Moderate Hepatic Impairment (MK-8527-015)
Non-randomizedParallel-groupOpen-labelBasic science
Summary
The purpose of this study is to learn what happens to MK-8527 in a person's body over time (a pharmacokinetic \[PK\] study). Researchers will compare what happens to MK-8527 in the body when it is given to healthy participants and participants with mild and moderate hepatic (liver) impairment.
Timeline
- Start
- 2025-09-19
- Primary completion
- 2026-02-13
- Completion
- 2026-02-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MK-8527 | Small molecule | — | Oral |
Indications
No indication recorded.